Mornington Medical Ltd

Contents

Balance Sheet	1 to 2
Notes to the Unaudited Financial Statements	1

Mornington Medical Ltd

(Registration number: 09466675)
Balance Sheet as at 31 March 2025

	2025 £	2024 £
Fixed assets	48,297	5,134
Current assets	4,539	7,290
Creditors: Amounts falling due within one year	(6,767)	(8,275)
Net current liabilities	(2,228)	(985)
Total assets less current liabilities	46,069	4,149
Creditors: Amounts falling due after more than one year	(33,913)	-
	12,156	4,149
Capital and reserves	12,156	4,149

1	General information

The company is a private company limited by share capital, incorporated in England & Wales.

The company's registered number is 09466675.

The address of its registered office is:
5 High Green
Great Shelford
Cambridge
CB22 5EG

These financial statements were authorised for issue by the Board on 22 December 2025.

2	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2024 - 0).

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Mornington Medical Ltd

(Registration number: 09466675)
Balance Sheet as at 31 March 2025

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 22 December 2025 and signed on its behalf by:
 

......................................... Dr Ronan O'Leary Director